SCHEMBL6101464

SCHEMBL6101464

Cc1cc(C)c(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NCCC1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.43
PIK3CB P42338 1/20 0.43
PIK3CG P48736 1/20 0.43
OPRL1 P41146 2/20 0.41
BRD4 O60885 1/20 0.41
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38
CNR2 P34972 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
SFRP1 Q8N474 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617527 0.89 SFRP1 (0.49) PIK3CDPIK3CBPIK3CGOPRL1BRD4
SCHEMBL4617455 0.89 SFRP1 (0.46) PIK3CDPIK3CBPIK3CGBRD4LMNA
SCHEMBL4616241 0.85 PIK3CD (0.39) PIK3CDPIK3CBPIK3CGOPRL1BRD4
SCHEMBL6103336 0.81 HTT (0.43) PIK3CDPIK3CBPIK3CGBRD4LMNA
SCHEMBL4637629 0.81 PIK3CD (0.41) PIK3CDPIK3CBPIK3CGOPRL1BRD4
SCHEMBL4619001 0.80 SFRP1 (0.41) PIK3CDPIK3CBPIK3CGBRD4SMN1; SMN2
SCHEMBL4618967 0.80 SFRP1 (0.61) PIK3CDPIK3CBPIK3CGBRD4LMNA
SCHEMBL4618971 0.78 TP53 (0.47) LMNASMN1; SMN2CNR2ALDH1A1TSHR
SCHEMBL4618055 0.78 GBA1 (0.50) SMN1; SMN2CNR2ALDH1A1TSHRL3MBTL1
SCHEMBL4733368 0.75 CHRM2 (0.41) PIK3CDPIK3CBPIK3CGOPRL1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 PIK3CD 3716/4885PIK3CB 3946/4885PIK3CG 4233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.